Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
Noam Barda(Ben-Gurion University of the Negev), Noa Dagan(Clalit Health Services), Cyrille J. Cohen(Bar-Ilan University), Miguel A. Hernán(Harvard University), Marc Lipsitch(Center for Disease Dynamics, Economics & Policy), Isaac S. Kohane(Harvard University), Ben Y. Reis(Family Research Institute), Ran D. Balicer(Family Research Institute)
Cited by 940Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis